Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Edap Technomed

This article was originally published in The Gray Sheet

Executive Summary

Edap Technomed: Inks separate, non-exclusive licensing deals with Urologix and Boston Scientific covering "all Edap issued or pending patents" worldwide that pertain to Edap's technology for microwave treatment of benign prostatic hyperplasia, Urologix and BS jointly announce. The agreements include "an initial license fee as well as prepaid and ongoing royalty payments, which are subject to a maximum royalty amount." Specific terms were not disclosed. Boston Scientific distributes Urologix' T3 system for BPH treatment in markets outside the U.S. and Japan ("The Gray Sheet" July 1, In Brief). Edap received FDA clearance for its Prostatron microwave-based system for treatment of BPH in May ("The Gray Sheet" May 13, I&W-1)...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT006513

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel